Evidence map›Paper›PMID 40535629›Full record

ArticleAmerican journal of translational research2025

Safety and efficacy of rescue endovascular treatment in ischemic stroke patients with early neurological deterioration caused by large vessel occlusion.

Mengmeng Chen, Jun Cao, Yao Li, Weimin Yang, Ruiqi Jia, Shuiping Wang, Yang Liu, Jingye Wang

Abstract read
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mengmeng ChenDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.
Jun CaoDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.
Yao LiDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.
Weimin YangDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.
Ruiqi JiaDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.
Shuiping WangDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.
Yang LiuAnhui Medical University Hefei, Anhui, China.
Jingye WangDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe optimal treatment after deterioration following ischemic stroke has not been established in the current guidelines. Therefore, this study evaluated the efficacy of rescue endovascular treatment in patients with early neurological deterioration after acute ischemic stroke.

methodsThis study analyzed data retrospectively retrieved from the electronic medical records at the First Affiliated Hospital of Anhui Medical University.

resultsA total of 20 patients were included in the rescue endovascular treatment group and 23 in the medical group. The 90-day favorable outcome rate in the rescue endovascular treatment group was significantly better than that of the medical group (75.0%

conclusionRescue endovascular treatment is effective and safe for patients with ischemic stroke and deterioration due to large vessel occlusion, leading to no significant increase in the risk of hemorrhage or death even when the time window exceeds 24 h.

Indexed as

Acute ischemic strokeearly neurological deteriorationlarge vessel occlusionprognosisrescue endovascular treatment

Identifiers

PMID40535629
PMCPMC12170376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.